1. Home
  2. MAN vs XNCR Comparison

MAN vs XNCR Comparison

Compare MAN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

N/A

Current Price

$46.07

Market Cap

2.5B

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$38.49

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAN
XNCR
Founded
1948
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
MAN
XNCR
Price
$46.07
$38.49
Analyst Decision
Hold
Buy
Analyst Count
12
14
Target Price
★ $51.94
$42.50
AVG Volume (30 Days)
911.0K
★ 1.6M
Earning Date
10-15-2026
11-04-2026
Dividend Yield
★ 3.12%
N/A
EPS Growth
N/A
★ 65.36
EPS
★ 1.89
N/A
Revenue
★ $17,957,100,000.00
$125,576,000.00
Revenue This Year
$6.51
$57.39
Revenue Next Year
$3.29
N/A
P/E Ratio
$24.28
★ N/A
Revenue Growth
0.58
★ 13.65
52 Week Low
$25.15
$10.38
52 Week High
$63.88
$40.60

Technical Indicators

Market Signals
Indicator
MAN
XNCR
Relative Strength Index (RSI) 44.18 74.05
Support Level $25.57 $11.05
Resistance Level $48.48 N/A
Average True Range (ATR) 1.67 2.30
MACD 0.40 0.98
Stochastic Oscillator 47.54 82.63

Price Performance

Historical Comparison
MAN
XNCR

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: